What is Vibrocil, dosing spray and when is it used?

Vibrocil contains a mild decongestant and an antihistamine. Vibrocil provides rapid and lasting relief from nasal congestion (blocked nose) and runny nose.

Vibrocil is suitable for the short-term symptomatic treatment of blocked nose and itching such as colds, sinusitis (inflammation of the paranasal sinuses), hay fever, allergic non-seasonal rhinitis (inflammation of the nasal mucosa, e.g. triggered by house dust, animal hair, mould).

With a doctor's prescription, Vibrocil can also be used before or after surgery and as an adjuvant drug in the treatment of acute middle ear infections.

When must Vibrocil, dosing spray not be used?

Vibrocil must not be used in the following cases:

• if you are hypersensitive to one of the active ingredients (dimethine maleate, phenylephrine) or to one of the excipients according to the composition,
• if you suffer from chronic rhinitis that has led to thinning of the nasal mucosa,
• if you are currently taking or have taken within the last 14 days monoamine oxidase inhibitors (MAOIs, medicines for depression),
• if you have glaucoma (i.e. an eye disease with increased pressure in the eye) ,
• after transnasal surgery (surgical interventions in the nose area where the inner skin was exposed).

When should you use Vibrocil, dosing spray Caution required?

Talk to your doctor before use if you have

• high blood pressure, cardiovascular disease,
• overactive thyroid,
• diabetes or
• epilepsy are suffering,
• have difficulty urinating (e.g. prostatic hypertrophy),
• are taking medicines to lower blood pressure (e.g. beta-blockers), mood-enhancing medicines (MAOIs, tri- or tetracyclic antidepressants) or anti-Parkinson medicines ( See also «When should Vibrocil not be used?»).

Vibrocil should not be used continuously for more than 3 days. If there is no improvement after 3 days or if the symptoms worsen, you should seek medical advice. Long-term or excessive use can cause chronic inflammation of the nasal mucosa (rhinitis medicamentosa).

Vibrocil can cause insomnia, drowsiness and tremors in sensitive individuals.

Vibrocil is not intended for use in the mouth or in the eyes.

The prescribed dose must not be exceeded, especially for small children and the elderly.

Vibrocil dosing spray is not recommended for children under 6 years of age.

The nose drops should be used for children between the ages of 2 and 6 years.

Vibrocil should be used in children from 2 to 12 years of age under adult supervision.

Information on the excipients

Benzalkonium chloride can cause irritation or swelling of the nasal mucosa, especially with prolonged use.

Tell your doctor, pharmacist or druggist if you

• suffer from other diseases,
• have allergies or
• use other medicines (including those you bought yourself!)!

Can Vibrocil, dosing spray be used during pregnancy or breastfeeding?

Systematic scientific studies have never been carried out. Phenylephrine and dimetindene maleate may be excreted in breast milk. As a precaution, Vibrocil should therefore not be used during pregnancy and breastfeeding.

How do you use Vibrocil, dosing spray?

Do not exceed the indicated dosage and application frequency.

The lowest effective dose should always be used over the shortest possible duration of therapy.

Adults and children over 6 years of age (with adult supervision):

Apply 1-2 mists into each nostril 3 to 4 times daily.

Children under 6 years of age

Vibrocil dosing spray is not recommended for children under 6 years of age.

Application of the dosing spray

• Clean your nose thoroughly before use (e.g. blow your nose).
• Be careful not to let the spray mist into the eyes.
• Remove protective cap. Before the very first use, press the pump 5 times to start the spraying process. The dosing spray is now ready for any further application. If the product has not been used for a long time, the pump must be operated 5 times again before use.
• Insert the spray head into one nostril, spray 1 time (press firmly) and inhale through your nose at the same time . Repeat the process for the other nostril.
• Wipe and dry the spray head before replacing the protective cap.

A bottle of Vibrocil dosing spray should only be used by one person to avoid possible spread of infection.

Do not use continuously for more than 3 days. If there is no improvement after 3 days or if the symptoms worsen, you should seek medical advice.

Stick to the dosage given in the package leaflet or as prescribed by your doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist.

What side effects can Vibrocil, dosing spray have?

The following side effects can occur when using Vibrocil:

In In rare cases (affects 1 to 10 users in 10,000), local and temporary burning or dryness of the nose and nosebleeds may occur.

If you get any side effects, talk to your doctor, pharmacist or druggist. This also applies in particular to side effects that are not listed in this leaflet.

What else needs to be considered?

Shelf life

The medicinal product may only be used up to the date marked on the container with « EXP» can be used.

Storage instructions

Keep out of the reach of children.

Vibrocil dosing spray: Protect from light and store at 15-30°C.

Further information

Your doctor, pharmacist or druggist can provide you with further information. These people have the detailed information for specialists.

What does Vibrocil dosing spray contain?

Active substances

1 ml Vibrocil dosing spray contains: 0.25 mg dimetindene maleate and 2.5 mg phenylephrine.

1 spray (=0.14 ml) contains: 0.035 mg dimetindene maleate and 0.35 mg phenylephrine.

Excipients

Sorbitol, sodium monohydrogen phosphate, citric acid monohydrate, lavandin oil, benzalkonium chloride, purified water.

Approval number

50421 (Swissmedic).

Where can you get Vibrocil, dosing spray? What packs are available?

In pharmacies and drugstores, without a doctor's prescription.

Vibrocil dosing spray (microdoseur): pack of 15 ml.

Authorization holder

GSK Consumer Healthcare Schweiz AG, Risch.

This package leaflet was last checked by the Medicines Agency (Swissmedic) in January 2021.